scispace - formally typeset
F

Fatima Bosch

Researcher at Autonomous University of Barcelona

Publications -  186
Citations -  8923

Fatima Bosch is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Insulin & Adipose tissue. The author has an hindex of 50, co-authored 175 publications receiving 7920 citations. Previous affiliations of Fatima Bosch include University of Barcelona & Carlos III Health Institute.

Papers
More filters
Journal ArticleDOI

Telomerase Gene Therapy in Adult and Old Mice Delays Aging and Increases Longevity Without Increasing Cancer

TL;DR: A proof‐of‐principle of a role of TERT in delaying physiological aging and extending longevity in normal mice through a telomerase‐based treatment is formed, and the feasibility of anti‐aging gene therapy is demonstrated.
Journal ArticleDOI

Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus

TL;DR: This animal model shows that primary alterations in the rate of liver glucose production may induce insulin resistance and NIDDM.
Journal ArticleDOI

Adipose Tissue Overexpression of Vascular Endothelial Growth Factor Protects Against Diet-Induced Obesity and Insulin Resistance

TL;DR: It is suggested that overexpression of VEGF in adipose tissue is a potential therapeutic strategy for the prevention of obesity and insulin resistance.
Journal ArticleDOI

High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

TL;DR: Vectors purified by the optimized CsCl protocol were found to be comparable in purity and functional activity to those prepared by more scalable, but less flexible serotype-specific purification processes developed for manufacture of clinical vectors, and are ideally suited for pre-clinical studies supporting translational research.
Journal ArticleDOI

Increased Fatty Acid Re-esterification by PEPCK Overexpression in Adipose Tissue Leads to Obesity Without Insulin Resistance

TL;DR: The results suggest that higher fat mass without increased circulating FFAs does not lead to insulin resistance or type 2 diabetes in these mice, and the key role of PEPCK in the control of FFA re-esterification in adipose tissue is indicated.